Metastatic adenocarcinoma of left supraclavicular fossa from occult primary ovarian cancer

Taiwanese Journal of Obstetrics and Gynecology

Volumn 50, Issue 1, 2011, Pages 98-99

  Wu, Wan Ju ^a   Ding, Dah Ching ^b   Chao, Tai Kung ^a   Liu, Yung Liang ^a   Hwang, Kwei Shuai ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; PACLITAXEL; TUMOR MARKER;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; CASE REPORT; CERVICAL LYMPHADENOPATHY; CYTOREDUCTIVE SURGERY; FEMALE; HISTOPATHOLOGY; HUMAN; LAPAROTOMY; LYMPH NODE DISSECTION; LYMPH NODE HYPERPLASIA; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT CANCER; OMENTECTOMY; OVARY ADENOCARCINOMA; OVARY CANCER; PAPILLARY CARCINOMA; PELVIS; PRIMARY TUMOR; SALPINGOOOPHORECTOMY;

ADENOCARCINOMA; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; OVARIAN NEOPLASMS;

EID: 79953788047     PISSN: 10284559     EISSN: 10284559     Source Type: Journal    
DOI: 10.1016/j.tjog.2011.01.003     Document Type: Article

References (5)

1. Mahoney E.J., Spiegel J.H. Evaluation and management of malignant cervical lymphadenopathy with an unknown primary tumor. Otolaryngol Clin North Am 2005, 38:87-97. viii-ix.
2. Mayadevi S., Nagarajan S., Van Der Voet J.C., Nevin J., Cruickshank D.J. Metastatic adenocarcinoma of right supraclavicular fossa-delayed presentation of ovarian primary. J Obstet Gynaecol 2005, 25:528-529.
3. Dvoretsky P.M., Richards K.A., Angel C., Rabinowitz L., Stoler M.H., Beecham J.B., et al. Distribution of disease at autopsy in 100 women with ovarian cancer. Hum Pathol 1988, 19:57-63.
4. Curtin J.P., Malik R., Venkatraman E.S., Barakat R.R., Hoskins W.J. Stage IV ovarian cancer: impact of surgical debulking. Gynecol Oncol 1997, 64:9-12.
5. Aletti G.D., Dowdy S.C., Podratz K.C., Cliby W.A. Analysis of factors impacting operability in stage IV ovarian cancer: rationale use of a triage system. Gynecol Oncol 2007, 105:84-89.